ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

Eight Practicing Physicians On Board are Enough, Need Some Scientists Now, DeVita Says

December 9, 1983

Afinitor and Sutent Approved For Pancreatic Neuroendocrine Tumors

May 27, 2011

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002

What? Only a “B”? NLST Co-Principal Investigator Begs to Differ with USPSTF Lung Cancer Screening Grade

August 9, 2013

Advocacy. Bypass Budget Treated As Serious Funding Request By Advocates

January 30, 1998

New NCAB Weak In Grant Reviews, Confused By Issues

December 10, 1982